Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 7Prostatic Neoplasms 4Oropharyngeal Neoplasms 3Laryngeal Neoplasms 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Mouth Neoplasms 2Mesothelioma 2Hypopharyngeal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma 2Astrocytoma 2Vaginal Neoplasms 1Urothelial Carcinoma of the Bladder 1Tongue Neoplasms 1Sarcoma 1Salivary Gland Neoplasms 1PSA Level Greater Than Two 1Oligodendroglioma 1Nasopharyngeal Carcinoma 1Mesothelioma, Malignant 1Lymphoma, Follicular 1Lymphoid Interstitial Pneumonia 1Lung Neoplasms 1Locally Advanced Cervical Adenocarcinoma 1Head and Neck Neoplasms 1Glioma 1Glioblastoma 1Extensive Stage Small Cell Lung Carcinoma 1Carcinoma, Squamous Cell 1

Interventions

trastuzumab deruxtecan 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Platinum 1Congresses as Topic 1Cisplatin 1Bupropion 1Brachytherapy 1Axitinib 13-aminopyridine-2-carboxaldehyde thiosemicarbazone 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vaginal Neoplasms × Radiotherapy, Intensity-Modulated × 30 days × Clear all
NCT02466971 2026-05-29

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

National Cancer Institute (NCI)

Phase 3 Active not recruiting
450 enrolled 11 charts
Gynecologic

Uterine Cervical Neoplasms, Vaginal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡